<DOC>
	<DOCNO>NCT00585000</DOCNO>
	<brief_summary>This show CP-675,206 administer safely intravenous infusion last one hour . CP 675,206 already administer 835 subject 1.0 - 7.5 hour .</brief_summary>
	<brief_title>A Study To Assess The Safety Of Administering CP-675,206 As A One Hour Infusion In Patients With Surgically Incurable Advanced Melanoma</brief_title>
	<detailed_description>This study prematurely discontinue April 28 , 2008 concomitant Phase 3 study meet pre-specified futility criterion . The decision close enrollment early base safety concern .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Tremelimumab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Histologically confirm melanoma surgically incurable Note : Prior therapy melanoma , include cancer vaccine , permit require . There limit number prior regimen melanoma patient may receive . Evidence least one lesion Eastern Cooperative Oncology Group ( ECOG ) performance status 01 CT scan brain contrast MRI brain within 6 week prior enrollment show evidence active brain metastasis . PET scan PET/CT scan also acceptable . Previous treatment anti CTLA4 agent ( eg , ipilimumab , MDX 010 ) . Previously randomize Pfizer study A3671009 : A Phase 3 , Open Label , Randomized Comparative Study CP 675,206 Either Dacarbazine Temozolomide Patients Advanced Melanoma . History chronic autoimmune disease ( eg , Addison 's disease , multiple sclerosis , Graves disease , Hashimoto 's thyroiditis , psoriasis , rheumatoid arthritis , systemic lupus erythematosus , hypophysitis , etc. ) . History inflammatory bowel disease ( eg , Crohn 's disease ulcerative colitis ) , celiac disease , chronic gastrointestinal condition associate diarrhea , current acute colitis origin , history diverticulitis ( even single episode ) evidence diverticulitis baseline , include evidence limit CT scan . Brain metastases adequately treat surgery stereotactic radiosurgery stable least 3 month prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>